Endometriosis, a painful condition affecting about 10% of women of reproductive age, has been historically under-researched, but recent studies are uncovering new insights. Advances in genetics have revealed genetic markers linked to endometriosis, opening pathways for targeted treatments. However, drug development has stalled, with many potential therapies showing limited effectiveness or side effects. Promising treatments like GnRH antagonists and aromatase inhibitors are emerging, although challenges remain, particularly for fertility preservation. Innovations in genomics and proteomics hold potential for personalized treatment, offering hope for improved, individualized care for those with endometriosis.
Free Shipping
on orders $49+
Wholesale
& Buying Club Price Discounts